About Us

/ABOUT US

Plasticell is a biotechology company developing therapies through precise manipulation of stem cells and more differentiated cell types using award-winning combinatorial screening technology.

We are advancing a number of therapeutic programs, including the expansion of hematopoietic stem cells from bone marrow and cord blood, the manufacture of red blood cells, platelets and immune cells from induced pluripotent stem cells (iPSCs).

Our combinatorial screening technology, CombiCultĀ®, allows us to test large numbers of cell culture variables to derive optimal laboratory protocols for any given outcome in cell biology, including cell expansion and differentiation, gene transduction and protein production, as well as the provision of human cells for drug screening.

Plasticell collaborates with leading universities and industry partners to facilitate discovery and improve product manufacturing in a variety of high value areas such as cell therapy, gene therapy, cancer immunotherapy and drug discovery.